How Would You Manage This Patient With Benign Prostatic Hyperplasia?
Annals of Internal Medicine · 2023
DOI: 10.7326/m23-0113 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Gerald W Smetana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (G.W.S., C.C.S., A.S., H.L.). Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Teaching Rounds. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) are common in older patients assigned male sex at birth, regardless of gender identity, and treatment of these symptoms is therefore common in primary care practice. In 2021, the American Urological Association published guidelines for management of BPH. They recommend using a standardized scoring system such as the International Prostate Symptom Score to help establish a diagnosis and to monitor the efficacy of interventions, α-blockers as the first-choice pharmacotherapy option, and 5α-reductase inhibitors for patients with prostate size estimated to be at least 30 cc. Tadalafil is another option regardless of erectile dysfunction. Combination therapies with α-blockers and 5α-reductase inhibitors, anticholinergic agents, or β3-agonists are effective options. A surgical referral is warranted if the BPH results in chronic kidney disease, refractory urinary retention, or recurrent urinary tract infections; if there is concern for bladder or prostate cancer; or if symptoms do not respond to medical therapy. In this article, a general internal medicine physician and a urologist discuss the treatment options and how they would apply their recommendations to a patient who wishes to learn more about his options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (G.W.S., C.C.S., A.S., H.L.).
Zitieren
APA
Smetana, G. W., Smith, C. C., Singla, A., & Libman, H. (2023). How Would You Manage This Patient With Benign Prostatic Hyperplasia?. Annals of Internal Medicine. https://doi.org/10.7326/m23-0113
Vancouver
Smetana GW, Smith CC, Singla A, Libman H. How Would You Manage This Patient With Benign Prostatic Hyperplasia?. Annals of Internal Medicine. 2023. doi:10.7326/m23-0113
BibTeX
@article{Smetana2023,
author = {Smetana, Gerald W and Smith, C Christopher and Singla, Ajay and Libman, Howard},
title = {How Would You Manage This Patient With Benign Prostatic Hyperplasia?},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/m23-0113}
}
EUVIMED